ZYUS Life Sciences Corporation (TSXV:ZYUS)

Market Cap	63.20M
Revenue (ttm)	452.00K
Net Income (ttm)	-36.55M
Shares Out	74.36M
EPS (ttm)	-0.52
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,500
Average Volume	2,255
Open	0.850
Previous Close	0.850
Day's Range	0.850 - 0.850
52-Week Range	0.700 - 1.190
Beta	n/a
RSI	51.39
Earnings Date	May 8, 2025

About ZYUS Life Sciences

ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada and internationally. The company offers cannabinoid oils, softgel capsules, and topical creams. ZYUS Life Sciences Corporation was founded in 2018 and is based in Saskatoon, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2018
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: ZYUS

Financial Performance

In 2023, ZYUS Life Sciences's revenue was 351,000, an increase of 17.79% compared to the previous year's 298,000. Losses were -42.59 million, 72.7% more than in 2022.